The article Cybin Buys License to Mindset Pharma’s Psychedelic Compounds was originally published on Microdose. Cybin Obtains Exclusive License to a...
The article Breaking News: Silo Pharma Uplists to the NASDAQ was originally published on Microdose. In surprising industry news, Silo Pharma has uplisted...
The article News You Might Have Missed: Sep 26th, 2022 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
The article HAVN Life Shutting Down? was originally published on Microdose. Unfortunate news for investors in HAVN Life Sciences as it seems the company...
Havn said it is actively seeking new funding, but it might not be successful. The post Havn Life Sciences Faces Bankruptcy, Cash Crunch Cuts Runway appeared...
The article MindMed Doses First Patients in Phase 1 MDMA Trial was originally published on Microdose. MindMed Collaborators Dose First Subject in Phase...
Traditional psychedelics have shown great potential for treating issues like depression, anxiety, PTSD, and addiction. Psilocybin and MDMA will likely...
Source: Francois Brisebois 09/13/2022 One Phase 2 clinical trial showing LSD reduced symptoms of anxiety bodes well for other studies of...
The article MindMed Retains its NASDAQ Listing was originally published on Microdose. Last month, MindMed announced a 1:15 reverse stock split. While...
Source: Daniel Patrick Martin / Shutterstock.com MindMed (NASDAQ:MNMD) stock is in the news Wednesday after the psychedelic medicine company regained...